Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy
Systems biological analysis has recently revealed how innate immune variants as well as gut microbiota impact the individual response to immunization. HIV-infected (HIV+) patients have a worse response rate after standard vaccinations, possibly due to the immune exhaustion, increased gut permeabilit...
Saved in:
Main Authors: | Edione C. Reis (Author), Lais T. da Silva (Author), Wanessa C. da Silva (Author), Alexandre Rios (Author), Alberto J. Duarte (Author), Telma M. Oshiro (Author), Sergio Crovella (Author), Alessandra Pontillo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenotypic and functional profile of IFN-α-differentiated dendritic cells (IFN-DCs) from HIV-infected individuals
by: Bruna Tereso Santillo, et al.
Published: (2019) -
42 Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individuals
by: L.o.d.o.r.o. Te Silva, da, et al.
Published: (2016) -
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020) -
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
by: Shumin Luo, et al.
Published: (2023) -
Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
Published: (2020)